{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:46:21Z","timestamp":1783028781240,"version":"3.54.6"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871513"],"award-info":[{"award-number":["31871513"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671202"],"award-info":[{"award-number":["31671202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2018714"],"award-info":[{"award-number":["BE2018714"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province","doi-asserted-by":"publisher","award":["017-WSW-033"],"award-info":[{"award-number":["017-WSW-033"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006765","name":"Chinese Medical Association","doi-asserted-by":"publisher","award":["17020350704"],"award-info":[{"award-number":["17020350704"]}],"id":[{"id":"10.13039\/501100006765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening, iatrogenic complication of ovarian stimulation in assisted reproduction technology. This complex syndrome is characterised by enlarged ovaries with multiple corpora luteum, elevated sex steroid hormones in serum and increased capillary permeability. Until now, the pathogenesis of OHSS remains obscure, and no absolute strategy can fully prevent OHSS without any side effect on ovulation and clinical pregnancy. Using cultured human or mouse granulosa cells, our study revealed the time-dependent activation of the mTOR signaling pathway after human chorionic gonadotropin (hCG) treatment. The involvement of the mTOR signaling pathway was also observed in the development of OHSS in a mouse model. Selectively inhibiting mTOR signals by only two injections of rapamycin (2\u00a0mg\/kg body weight), before or just after hCG treatment, significantly reduced vascular leakage and the severity of OHSS symptoms. Although ovarian angiogenesis was significantly inhibited, rapamycin could not decrease the elevated levels of vascular endothelial growth factor, IL-6 and IL-11 in OHSS ovaries. Further study showed the functional roles of the mTOR signaling pathway in the hyperstimulation-induced ovarian extracellular matrix remodeling as the expression of \u03b12M, a broad proteolytic inhibitor in both ovary and serum, was dramatically decreased after rapamycin treatment. Since a single injection of rapamycin during superovulation had no side effects on ovulation and early embryonic development, we propose rapamycin may be a good candidate to lower and prevent the risk of OHSS in the future.<\/jats:p>","DOI":"10.1093\/molehr\/gaz033","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T07:13:07Z","timestamp":1562915587000},"page":"445-457","source":"Crossref","is-referenced-by-count":11,"title":["Successful reversal of ovarian hyperstimulation syndrome in a mouse model by rapamycin, an mTOR pathway inhibitor"],"prefix":"10.1093","volume":"25","author":[{"given":"Wenwen","family":"Liu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center of Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center of Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-4981","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"key":"2019091013290644200_ref1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019091013290644200_ref2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0015-0282(97)81908-5","article-title":"Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome","volume":"67","author":"Abramov","year":"1997","journal-title":"Fertil Steril"},{"key":"2019091013290644200_ref3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0015-0282(98)00447-6","article-title":"Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome","volume":"71","author":"Agrawal","year":"1999","journal-title":"Fertil Steril"},{"key":"2019091013290644200_ref4","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1210\/me.2005-0114","article-title":"Estrogen-induced abnormally high cystic fibrosis transmembrane conductance regulator expression results in ovarian hyperstimulation syndrome","volume":"19","author":"Ajonuma","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2019091013290644200_ref5","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2019091013290644200_ref6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"2019091013290644200_ref7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1872214808666140606142820","article-title":"Neurovascular complications of ovarian hyperstimulation syndrome (OHSS): from pathophysiology to recent treatment options","volume":"8","author":"Calabro","year":"2014","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"2019091013290644200_ref8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/humrep\/15.5.1037","article-title":"Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome","volume":"15","author":"Chen","year":"2000","journal-title":"Hum Reprod"},{"key":"2019091013290644200_ref9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/er.2002-0005","article-title":"The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle","volume":"24","author":"Curry","year":"2003","journal-title":"Endocr Rev"},{"key":"2019091013290644200_ref10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/molehr\/3.1.27","article-title":"Matrix metalloproteinases as mediators of reproductive function","volume":"3","author":"Hulboy","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"2019091013290644200_ref11","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1158\/0008-5472.CAN-05-2825","article-title":"Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimus","volume":"66","author":"Del Bufalo","year":"2006","journal-title":"Cancer Res"},{"key":"2019091013290644200_ref12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02765823","article-title":"Features of the renin-angiotensin system in ascites and pleural effusion during severe ovarian hyperstimulation syndrome","volume":"14","author":"Delbaere","year":"1997","journal-title":"J Assist Reprod Genet"},{"key":"2019091013290644200_ref13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/ENDO:26:3:285","article-title":"Understanding ovarian hyperstimulation syndrome","volume":"26","author":"Delbaere","year":"2005","journal-title":"Endocrine"},{"key":"2019091013290644200_ref14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/acel.12617","article-title":"Short-term rapamycin treatment increases ovarian lifespan in young and middle-aged female mice","volume":"16","author":"Dou","year":"2017","journal-title":"Aging Cell"},{"key":"2019091013290644200_ref15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/humrep\/12.6.1129","article-title":"The pathophysiology of ovarian hyperstimulation syndrome\u2014views and ideas","volume":"12","author":"Elchalal","year":"1997","journal-title":"Hum Reprod"},{"key":"2019091013290644200_ref16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9110152","article-title":"Evolving significance and future relevance of anti-angiogenic activity of mTOR inhibitors in cancer therapy","volume":"9","author":"Faes","year":"2017","journal-title":"Cancers (Basel)"},{"key":"2019091013290644200_ref17","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.fertnstert.2008.08.129","article-title":"Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model","volume":"92","author":"Fainaru","year":"2009","journal-title":"Fertil Steril"},{"key":"2019091013290644200_ref18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2010.04.015","article-title":"mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivo","volume":"296","author":"Fuereder","year":"2010","journal-title":"Cancer Lett"},{"key":"2019091013290644200_ref19","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/en.2002-220204","article-title":"Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade","volume":"143","author":"Gomez","year":"2002","journal-title":"Endocrinology"},{"key":"2019091013290644200_ref20","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1095\/biolreprod.102.010801","article-title":"Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability","volume":"68","author":"Gomez","year":"2003","journal-title":"Biol Reprod"},{"key":"2019091013290644200_ref21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"2019091013290644200_ref22","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.transproceed.2008.10.009","article-title":"mTOR\u2014what does it do?","volume":"40","author":"Hall","year":"2008","journal-title":"Transplant Proc"},{"key":"2019091013290644200_ref23","doi-asserted-by":"crossref","first-page":"e2817","DOI":"10.1038\/cddis.2017.168","article-title":"Restricting the induction of NGF in ovarian stroma engenders selective follicular activation through the mTOR signaling pathway","volume":"8","author":"He","year":"2017","journal-title":"Cell Death Dis"},{"key":"2019091013290644200_ref24","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/REP-13-0296","article-title":"Regulation of endothelial permeability in the primate corpora lutea: implications for ovarian hyperstimulation syndrome","volume":"149","author":"Herr","year":"2015","journal-title":"Reproduction"},{"key":"2019091013290644200_ref25","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.fertnstert.2013.01.120","article-title":"Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins","volume":"99","author":"Herr","year":"2013","journal-title":"Fertil Steril"},{"key":"2019091013290644200_ref26","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1210\/en.2009-1032","article-title":"Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase","volume":"151","author":"Hou","year":"2010","journal-title":"Endocrinology"},{"key":"2019091013290644200_ref27","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/en.2003-1407","article-title":"Evidence for autocrine or paracrine roles of alpha2-macroglobulin in regulation of estradiol production by granulosa cells and development of dominant follicles","volume":"145","author":"Ireland","year":"2004","journal-title":"Endocrinology"},{"key":"2019091013290644200_ref28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00441-005-0042-y","article-title":"Extracellular matrix in ovarian follicular development and disease","volume":"322","author":"Irving-Rodgers","year":"2005","journal-title":"Cell Tissue Res"},{"key":"2019091013290644200_ref29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-5793(01)02897-6","article-title":"Diminished corneal angiogenesis in gelatinase A-deficient mice","volume":"508","author":"Kato","year":"2001","journal-title":"FEBS Lett"},{"key":"2019091013290644200_ref30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/09513590.2016.1188376","article-title":"The combination of Everolimus with Verapamil reduces ovarian weight and vascular permeability on ovarian hyperstimulation syndrome: a preclinical experimental randomized controlled study","volume":"32","author":"Kitsou","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2019091013290644200_ref31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/09513590.2015.1065479","article-title":"Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled study","volume":"31","author":"Kosmas","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2019091013290644200_ref32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/GCO.0000000000000284","article-title":"Pathophysiology, treatment and prevention of ovarian hyperstimulation syndrome","volume":"28","author":"Kwik","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019091013290644200_ref33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2019091013290644200_ref34","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/humrep\/14.10.2437","article-title":"Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration","volume":"14","author":"Ludwig","year":"1999","journal-title":"Hum Reprod"},{"key":"2019091013290644200_ref35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1113\/jphysiol.1952.sp004789","article-title":"Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs","volume":"118","author":"Miles","year":"1952","journal-title":"J Physiol"},{"key":"2019091013290644200_ref36","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1210\/jc.2016-1744","article-title":"The dual role of PEDF in the pathogenesis of OHSS: negating both angiogenic and inflammatory pathways","volume":"101","author":"Miller","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091013290644200_ref37","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1248\/bpb.b17-00475","article-title":"Mammalian target of rapamycin (mTOR) as a potential therapeutic target in pathological ocular angiogenesis","volume":"40","author":"Nakahara","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"2019091013290644200_ref38","first-page":"248","article-title":"Ovarian hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management","volume":"43","author":"Namavar Jahromi","year":"2018","journal-title":"Iran J Med Sci"},{"key":"2019091013290644200_ref39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10815-010-9387-6","article-title":"Ovarian hyperstimulation syndrome: pathophysiology and prevention","volume":"27","author":"Nastri","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"2019091013290644200_ref40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/uog.14684","article-title":"Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention","volume":"45","author":"Nastri","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2019091013290644200_ref41","doi-asserted-by":"crossref","first-page":"C595","DOI":"10.1152\/ajpcell.00133.2012","article-title":"Fluid shear stress induces differentiation of circulating phenotype endothelial progenitor cells","volume":"303","author":"Obi","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"2019091013290644200_ref42","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/humrep\/del005","article-title":"Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome","volume":"21","author":"Pau","year":"2006","journal-title":"Hum Reprod"},{"key":"2019091013290644200_ref43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(98)00484-1","article-title":"The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor","volume":"71","author":"Pellicer","year":"1999","journal-title":"Fertil Steril"},{"key":"2019091013290644200_ref44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2010.12.041","article-title":"Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP","volume":"656","author":"Pratheeshkumar","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2019091013290644200_ref45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/molehr\/7.4.325","article-title":"The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women","volume":"7","author":"Shalev","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"2019091013290644200_ref46","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/mrd.22333","article-title":"Mechanistic target of rapamycin (MTOR) signaling during ovulation in mice","volume":"81","author":"Siddappa","year":"2014","journal-title":"Mol Reprod Dev"},{"key":"2019091013290644200_ref47","first-page":"367","article-title":"Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function","volume":"54","author":"Smith","year":"1999","journal-title":"J Reprod Fertil Suppl"},{"key":"2019091013290644200_ref48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2019091013290644200_ref49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1096\/fj.01-0790com","article-title":"MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression","volume":"16","author":"Sounni","year":"2002","journal-title":"FASEB J"},{"key":"2019091013290644200_ref50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chest.2017.05.012","article-title":"Long-term effect of sirolimus on serum vascular endothelial growth factor D levels in patients with lymphangioleiomyomatosis","volume":"153","author":"Taveira-DaSilva","year":"2018","journal-title":"Chest"},{"key":"2019091013290644200_ref51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1196\/annals.1365.021","article-title":"Prevention and management of ovarian hyperstimulation syndrome","volume":"1092","author":"Vlahos","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"2019091013290644200_ref52","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1210\/jc.2012-3462","article-title":"The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model","volume":"98","author":"Wei","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019091013290644200_ref53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1757-2215-5-38","article-title":"The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)","volume":"5","author":"Yaba","year":"2012","journal-title":"J Ovarian Res"},{"key":"2019091013290644200_ref54","first-page":"913","article-title":"Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing","volume":"39","author":"Ye","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019091013290644200_ref55","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008046.pub2","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles","volume":"11","author":"Youssef","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2019091013290644200_ref56","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/1535-7163.MCT-11-0008","article-title":"Time-course imaging of therapeutic functional tumor vascular normalization by antiangiogenic agents","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"2019091013290644200_ref57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.anireprosci.2011.03.002","article-title":"Activation of PI3K\/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells","volume":"125","author":"Zhang","year":"2011","journal-title":"Anim Reprod Sci"}],"container-title":["Molecular Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/molehr\/advance-article-pdf\/doi\/10.1093\/molehr\/gaz033\/29118485\/gaz033.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/molehr\/article-pdf\/25\/8\/445\/29960985\/gaz033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T11:37:22Z","timestamp":1569238642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molehr\/article\/25\/8\/445\/5535751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,22]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/molehr\/gaz033","relation":{},"ISSN":["1460-2407"],"issn-type":[{"value":"1460-2407","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,7,22]]}}}